http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108976222-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5377 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-454 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-422 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-427 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04 |
| filingDate | 2018-09-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2021-09-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2021-09-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-108976222-B |
| titleOfInvention | Heterocyclic ring-containing biaryl oxazolidinone compound and preparation method thereof |
| abstract | The invention relates to a heterocyclic biaryl oxazolidinone compound shown as a general formula I, or an optical isomer, a pharmaceutically acceptable salt and/or a solvate thereof, a preparation method thereof and a pharmaceutical composition containing the compound. Wherein the substituent R 1 、R 2 、R 3 、R 4 And ring A has the meaning given in the description. The invention also relates to the application of the compounds and the pharmaceutically acceptable salts, solvates or prodrugs thereof as antibacterial agents in treatment, in particular to the application in treatment of gram-positive bacteria infection and tubercle bacillus infection. |
| priorityDate | 2018-09-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 155.